ASCO: Genentech touts bispecific data for DLBCL calling it 'groundbreaking' for heavily pretreated patients
https://www.fiercebiotech.com/biotech/genentech-wants-offer-easier-treatment-path-lymphoma-patients-whove-been-through-it-all
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.